John Doux insider trades

Open-market stock purchases and sales by John Doux, Director at Palvella Therapeutics, Inc, from SEC Form 4 filings since Apr 13, 2026.

Recent trades

DateStockTradeValue
Jun 10, 2026PVLA Palvella Therapeutics, IncBought (not open market)—
Apr 13, 2026PVLA Palvella Therapeutics, IncBought (not open market)—

Companies traded

  • PVLA Palvella Therapeutics, Inc: other filings, last Jun 10, 2026

Get free alerts when John Doux files a new trade →